DropSafe 1-3/8" Diameter film & foam round white sterile pre-injection adhesive strip
Protect Clinicians During Vaccination with DropSafe Inject-Safe Barrier Bandage
DropSafe Inject-Safe Barrier Bandage is a patented self-adhesive sterile bandage applied before subcutaneous or intramuscular injections. It controls post-injection bleeding, reducing healthcare worker exposure to bloodborne pathogens. This allows immediate activation of the safety mechanism and safe needle disposal with both hands.
How It Protects
- Creates a barrier to limit contact with the injection site.
- Enables quick activation of safety mechanisms and safe needle disposal.
- Eliminates the need to return to the injection site.
Vaccination Risks for Healthcare Workers
- Exposure to bloodborne pathogens from direct contact with the injection site.
- Needlestick injuries (NSIs) due to delayed activation of safety mechanisms.
EPINet Report (Jan–Dec 2019):
- 75% of NSIs with needles/syringes involved visible blood.
- 72% of NSIs with safety needles occurred due to failed safety activation.
Original: $36.43
-65%$36.43
$12.75Product Information
Product Information
Shipping & Returns
Shipping & Returns
Description
Protect Clinicians During Vaccination with DropSafe Inject-Safe Barrier Bandage
DropSafe Inject-Safe Barrier Bandage is a patented self-adhesive sterile bandage applied before subcutaneous or intramuscular injections. It controls post-injection bleeding, reducing healthcare worker exposure to bloodborne pathogens. This allows immediate activation of the safety mechanism and safe needle disposal with both hands.
How It Protects
- Creates a barrier to limit contact with the injection site.
- Enables quick activation of safety mechanisms and safe needle disposal.
- Eliminates the need to return to the injection site.
Vaccination Risks for Healthcare Workers
- Exposure to bloodborne pathogens from direct contact with the injection site.
- Needlestick injuries (NSIs) due to delayed activation of safety mechanisms.
EPINet Report (Jan–Dec 2019):
- 75% of NSIs with needles/syringes involved visible blood.
- 72% of NSIs with safety needles occurred due to failed safety activation.
